As previously observed with the A549 cells, MDA-MB-231 and MCF7 breast cancer cell lines stably expressing shRNAs targeting SREBP2 displayed increased fluvastatin sensitivity expressed as anti-proliferative and pro-apoptotic effects (Figure 4A–4F). The gene discussed is SREBF2; the disease is breast cancer.